News

Filter

Current filters:

Sandimmune

1 to 9 of 138 results

APT Pharma secures $32.3M financing

06-10-2008

APT Pharmaceuticals, a US specialty drug development company focused on inhaled treatments for serious…

3MCyclosporineNeoralRestasisSandimmune

Barr shares fall 15% on disappointing 1st qtr

19-05-2008

Shares in Barr Pharmaceuticals fell 15% in premarket trading on May 8, after the US generics giant reported…

CyclosporineCyclosporine CapsulesGengraf CapsulesNeoralNystatinOralRestasisSandimmune

US fast-track for Lux Biosciences' LX201

04-02-2008

Lux Biosciences, a privately-held US biotechnology company specialized in the field of ophthalmic diseases,…

CyclosporineNeoralRestasisSandimmune

Myfortic cuts GI effects in transplant recipients

14-01-2008

Data from a new study, published in the journal Transplantation, indicate that kidney transplant recipients…

CellCeptCyclosporineMycophenolate MofetilMycophenolic AcidMyforticNeoralNovartisPrografProtopicRestasisRocheSandimmunetacrolimus

New Rapamune dosing guide OKed by FDA

12-02-2007

New Jersey, USA-based Wyeth Pharmaceuticals says that the Food and Drug Administration has cleared new…

CyclosporineNeoralRapamuneRestasisSandimmunesirolimusWyeth

1 to 9 of 138 results

COMPANY SPOTLIGHT

Menarini

Back to top